Starting October 1, 2025, we invite general practitioners to participate in our survey on blood-based biomarkers for Alzheimer’s disease in primary care. Recent developments, such as the first blood test for Alzheimer’s diagnosis in the USA and the first amyloid-targeting drug in the EU, are increasingly shaping primary care consultations.
Qualitative interviews with general practitioners have shown that these developments raise both opportunities and concerns in everyday practice. Your insights will help develop practical informational materials and realistically prepare the care of patients with cognitive changes.
Your responses will, of course, be treated confidentially and anonymously.
We greatly appreciate your participation!
Please be aware that the survey is only available in German.
If you have any questions or would like more information about the survey, we are happy to assist you.
You can reach our project member, Dr. Anne Blawert, at anne.blawert@dzne.de